Organelle proteomics: Looking at less to see more

Trends in Cell Biology

Volumn 13, Issue 12, 2003, Pages 629-638

  Brunet, Sylvain ^a   Thibault, Pierre ^b   Gagnon, Etienne ^a   Kearney, Paul ^b   Bergeron, John J M ^b,c   Desjardins, Michel ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b Caprion Pharmaceuticals   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOINFORMATICS; CELL FUNCTION; CELL NUCLEUS; CELL ORGANELLE; CELLULAR DISTRIBUTION; CYTOLOGY; ENDOCYTOSIS; GENETIC ANALYSIS; GENOME; GOLGI COMPLEX; HUMAN; MASS SPECTROMETRY; MOLECULAR DYNAMICS; PHAGOCYTOSIS; PHAGOSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; REVIEW;

EID: 0242391970     PISSN: 09628924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcb.2003.10.006     Document Type: Review

References (73)

1. Jung E., et al. Proteomics meets cell biology: the establishment of subcellular proteomes. Electrophoresis. 21:2000;3369-3377.
2. Huber L.A. Is proteomics heading in the wrong direction? Nat. Rev. Mol. Cell Biol. 4:2003;74-80.
3. Patterson S.D., Aebersold R.H. Proteomics: the first decade and beyond. Nat. Genet. 33:(Suppl.):2003;311-323.
4. Palade G.E. Structure and function at the cellular level. JAMA. 198:1966;815-825.
5. De Duve C. The Lysosome concept. de Reuck A.V.S., Cameron M.P. Ciba Foundation Symposium. 1963;1-35 Churchill Livingstone.
6. Huber L.A., et al. Organelle proteomics: implications for subcellular fractionation in proteomics. Circ. Res. 92:2003;962-968.
7. Blackstock W.P., Weir M.P. Proteomics: quantitative and physical mapping of cellular proteins. Trends Biotechnol. 17:1999;121-127.
8. Gadal O., Nehrbass U. Nuclear structure and intranuclear retention of premature RNAs. J. Struct. Biol. 140:2002;140-146.
9. Dreger M., et al. Nuclear envelope proteomics: novel integral membrane proteins of the inner nuclear membrane. Proc. Natl. Acad. Sci. U.S.A. 98:2001;11943-11948.
10. Rout M.P., et al. The yeast nuclear pore complex: composition, architecture, and transport mechanism. J. Cell Biol. 148:2000;635-651.
11. Staley J.P., Guthrie C. Mechanical devices of the spliceosome: motors, clocks, springs, and things. Cell. 92:1998;315-326.
12. Neubauer G., et al. Mass spectrometry and EST-database searching allows characterization of the multi-protein spliceosome complex. Nat. Genet. 20:1998;46-50.
13. Rappsilber J., et al. Large-scale proteomic analysis of the human spliceosome. Genome Res. 12:2002;1231-1245.
14. Andersen J.S., et al. Directed proteomic analysis of the human nucleolus. Curr. Biol. 12:2002;1-11.
15. Fox A.H., et al. Paraspeckles: a novel nuclear domain. Curr. Biol. 12:2002;13-25.
16. Dundr M., Misteli T. Nucleolomics: an inventory of the nucleolus. Mol. Cell. 9:2002;5-7.
17. Wasiak S., et al. Enthoprotin: a novel clathrin-associated protein identified through subcellular proteomics. J. Cell Biol. 158:2002;855-862.
18. De Camilli P., et al. The ENTH domain. FEBS Lett. 513:2002;11-18.
19. de Duve C. Lysosomes revisited. Eur. J. Biochem. 137:1983;391-397.
20. Journet A., et al. Proteomic analysis of human lysosomes: application to monocytic and breast cancer cells. Proteomics. 2:2002;1026-1040.
21. Journet A., et al. Towards a human repertoire of monocytic lysosomal proteins. Electrophoresis. 21:2000;3411-3419.
22. Ni J., et al. Cystatin F is a glycosylated human low molecular weight cysteine proteinase inhibitor. J. Biol. Chem. 273:1998;24797-24804.
23. Nathanson C.M., et al. Regulated expression and intracellular localization of cystatin F in human U937 cells. Eur. J. Biochem. 269:2002;5502-5511.
24. Veal E., et al. The secreted glycoprotein CREG enhances differentiation of NTERA-2 human embryonal carcinoma cells. Oncogene. 19:2000;2120-2128.
25. Wunderlich W., et al. A novel 14-kilodalton protein interacts with the mitogen-activated protein kinase scaffold mp1 on a late endosomal/lysosomal compartment. J. Cell Biol. 152:2001;765-776.
26. Teis D., et al. Localization of the MP1-MAPK scaffold complex to endosomes is mediated by p14 and required for signal transduction. Dev. Cell. 3:2002;803-814.
27. Pasternak, S.H., et al. (2003) Presenilin, nicastrin and beta-amyloid production in the endosomal/ lysosomal system: toward a unifying model of Alzheimer's disease. J. Biol. Chem. (in press).
28. Pan B.T., et al. Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes. J. Cell Biol. 101:1985;942-948.
29. Johnstone R.M., et al. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J. Biol. Chem. 262:1987;9412-9420.
30. Denzer K., et al. Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J. Cell Sci. 113:2000;3365-3374.
31. Raposo G., et al. B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 183:1996;1161-1172.
32. Zitvogel L., et al. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat. Med. 4:1998;594-600.
33. Casciola-Rosen L.A., et al. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 179:1994;1317-1330.
34. Thery C., et al. Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73. J. Cell Biol. 147:1999;599-610.
35. Thery C., et al. Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J. Immunol. 166:2001;7309-7318.
36. Wubbolts R., et al. Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation. J. Biol. Chem. 278:2003;10963-10972.
37. Wolfers J., et al. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat. Med. 7:2001;297-303.
38. Santoni V., et al. Membrane proteomics: use of additive main effects with multiplicative interaction model to classify plasma membrane proteins according to their solubility and electrophoretic properties. Electrophoresis. 21:2000;3329-3344.
39. Dominguez M., et al. Fusogenic domains of golgi membranes are sequestered into specialized regions of the stack that can be released by mechanical fragmentation. J. Cell Biol. 145:1999;673-688.
40. Wu C.C., et al. Proteomic analysis of two functional states of the Golgi complex in mammary epithelial cells. Traffic. 1:2000;769-782.
41. Wu C.C., et al. GMx33: a novel family of trans-Golgi proteins identified by proteomics. Traffic. 1:2000;963-975.
42. Bell A., et al. Proteomics characterization of abundant Golgi membrane proteins. J. Biol. Chem. 276:2001;5152-5165.
43. Underhill D.M., Ozinsky A. Phagocytosis of microbes: complexity in action. Annu. Rev. Immunol. 20:2002;825-852.
44. Desjardins M. ER-mediated phagocytosis: a new membrane for new functions. Nat. Rev. Immunol. 3:2003;280-291.
45. Duclos S., Desjardins M. Subversion of a young phagosome: the survival strategies of intracellular pathogens. Cell. Microbiol. 2:2000;365-377.
46. Wetzel M.G., Korn E.D. Phagocytosis of latex beads by Acanthamoeba castellanii (Neff). 3. Isolation of the phagocytic vesicles and their membranes. J. Cell Biol. 43:1969;90-104.
47. Desjardins M., et al. Biogenesis of phagolysosomes proceeds through a sequential series of interactions with the endocytic apparatus. J. Cell Biol. 124:1994;677-688.
48. Garin J., et al. The phagosome proteome: insight into phagosome functions. J. Cell Biol. 152:2001;165-180.
49. Houde M., et al. Phagosomes are competent organelles for antigen cross-presentation. Nature. 425:2003;402-406.
50. Gagnon E., et al. Endoplasmic reticulum-mediated phagocytosis is a mechanism of entry into macrophages. Cell. 110:2002;119-131.
51. Muller-Taubenberger A., et al. Calreticulin and calnexin in the endoplasmic reticulum are important for phagocytosis. EMBO J. 20:2001;6772-6782.
52. McNew J.A., et al. Compartmental specificity of cellular membrane fusion encoded in SNARE proteins. Nature. 407:2000;153-159.
53. Watts C., Amigorena S. Phagocytosis and antigen presentation. Semin. Immunol. 13:2001;373-379.
54. Heath W.R., Carbone F.R. Cross-presentation in viral immunity and self-tolerance. Nat. Rev. Immunol. 1:2001;126-134.
55. Kovacsovics-Bankowski M., Rock K.L. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science. 267:1995;243-246.
56. Guermonprez P., et al. ER-phagosome fusion defines an MHC class 1 cross-presentation compartment in dendritic cells. Nature. 425:2003;397-402.
57. Dermine J.F., et al. Flotillin-1-enriched lipid raft domains accumulate on maturing phagosomes. J. Biol. Chem. 276:2001;18507-18512.
58. Wigge P.A., et al. Analysis of the Saccharomyces spindle pole by matrix-assisted laser desorption/ionization (MALDI) mass spectrometry. J. Cell Biol. 141:1998;967-977.
59. Lopez M.F., et al. High-throughput profiling of the mitochondrial proteome using affinity fractionation and automation. Electrophoresis. 21:2000;3427-3440.
60. Brookes P.S., et al. High-throughput two-dimensional blue-native electrophoresis: a tool for functional proteomics of mitochondria and signalling complexes. Proteomics. 2:2002;969-977.
61. Taylor S.W., et al. Characterization of the human heart mitochondrial proteome. Nat. Biotechnol. 21:2003;281-286.
62. Fountoulakis M., Schlaeger E.J. The mitochondrial proteins of the neuroblastoma cell line IMR-32. Electrophoresis. 24:2003;260-275.
63. Foster J.L., et al. Unbiased quantitative proteomics of lipid rafts reveals high specificity for signaling factors. Proc. Natl. Acad. Sci. U.S.A. 100:2003;5813-5818.
64. Karas M., Hillenkamp F. Laser desorption ionization of proteins with molecular mass exceeding 10000 Daltons. Anal. Chem. 60:1988;2299-2301.
65. Tanaka K., et al. Protein and polymer analyses up to m/z 100,000 by laser ionization time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 2:1988;151-153.
66. Fenn J.B., et al. Electrospray ionization for the mass spectrometry of large biomolecules. Science. 246:1989;64-71.
67. Aebersold R., Mann M. Mass-spectrometry-based proteomics. Nature. 422:2003;198-207.
68. O'Farrell P.H. High resolution two-dimensional electrophoresis of proteins. J. Biol. Chem. 250:1975;4007-4021.
69. Gygi S.P., et al. Evaluation of two-dimensional gel electrophoresis- based proteome technology. Proc. Natl. Acad. Sci. U.S.A. 97:2000;9390-9395.
70. Wolters D.A., et al. An automated multidimensional protein identification technology for shotgun proteomics. Anal. Chem. 73:2001;5683-5690.
71. Perkins D.N., et al. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis. 20:1999;3551-3567.
72. Ashburner M., et al. Gene ontology: tool for the unification of biology. Nat. Genet. 25:2000;25-29.
73. Mulder N.J., et al. The InterPro Database, 2003 brings increased coverage and new features. Nucleic Acids Res. 31:2003;315-318.